DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $388,277 | +2.1% | 1,565 | -1.3% | 0.06% | +9.3% |
Q2 2023 | $380,400 | +1.8% | 1,585 | +7.0% | 0.05% | -5.3% |
Q1 2023 | $373,523 | -18.8% | 1,482 | -14.5% | 0.06% | -20.8% |
Q4 2022 | $460,238 | +2.3% | 1,734 | -0.5% | 0.07% | -4.0% |
Q3 2022 | $450,000 | +0.4% | 1,742 | -1.4% | 0.08% | +2.7% |
Q2 2022 | $448,000 | -13.5% | 1,767 | 0.0% | 0.07% | +1.4% |
Q1 2022 | $518,000 | -11.0% | 1,767 | -0.1% | 0.07% | -7.7% |
Q4 2021 | $582,000 | +7.6% | 1,769 | -0.4% | 0.08% | -3.7% |
Q3 2021 | $541,000 | +23.8% | 1,776 | +9.1% | 0.08% | +1.2% |
Q2 2021 | $437,000 | +19.4% | 1,628 | 0.0% | 0.08% | +1.3% |
Q1 2021 | $366,000 | +1.1% | 1,628 | 0.0% | 0.08% | -4.8% |
Q4 2020 | $362,000 | +3.1% | 1,628 | 0.0% | 0.08% | -6.7% |
Q3 2020 | $351,000 | +2.9% | 1,628 | -15.6% | 0.09% | -16.8% |
Q2 2020 | $341,000 | -2.0% | 1,928 | -23.3% | 0.11% | -28.2% |
Q1 2020 | $348,000 | -15.7% | 2,514 | -6.6% | 0.15% | +0.7% |
Q4 2019 | $413,000 | +17.7% | 2,691 | +10.7% | 0.15% | +12.1% |
Q3 2019 | $351,000 | -10.0% | 2,431 | -11.0% | 0.13% | -14.3% |
Q2 2019 | $390,000 | +8.0% | 2,731 | 0.0% | 0.15% | -2.5% |
Q1 2019 | $361,000 | +7.1% | 2,731 | -16.4% | 0.16% | +16.2% |
Q4 2018 | $337,000 | -4.3% | 3,268 | +1.0% | 0.14% | +28.3% |
Q3 2018 | $352,000 | +17.7% | 3,235 | +6.7% | 0.11% | +6.0% |
Q2 2018 | $299,000 | -12.3% | 3,031 | -12.9% | 0.10% | -20.0% |
Q1 2018 | $341,000 | – | 3,480 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |